Lactase genetic polymorphisms and coeliac disease in children: a cohort study

Raja A H Kuchay1, Babu R Thapa, Akhtar Mahmood

  • 1Department of Experimental Medicine and Biotechnology, Postgraduate Institute of Medical Education and Research , Chandigarh , India .

Annals of Human Biology
|December 16, 2014
PubMed

Insights

This study found no significant link between coeliac disease (CD) and specific genetic markers for adult-type hypolactasia (AtH) in North Indian children. Children with certain AtH genotypes do not appear to have a higher risk of developing CD.

Area of Science:

  • Genetics and Gastroenterology
  • Pediatric Autoimmune Diseases
  • Human Population Studies

Background:

  • Adult-type hypolactasia (AtH) is common due to declining lactase activity in childhood.
  • Single nucleotide polymorphisms (SNPs) like C/T-13910 and G/A-22018 are linked to AtH.
  • Coeliac disease (CD) is an autoimmune disorder causing intestinal damage.

Purpose of the Study:

  • To investigate the association between coeliac disease (CD) and SNPs related to adult-type hypolactasia (AtH).
  • To analyze these associations in pediatric populations in North India.

Main Methods:

  • Collected intestinal biopsies and saliva samples from 52 children with CD and 102 controls.
  • Assayed disaccharidase activities in biopsies.
  • Genotyped samples for C/T-13910 and G/A-22018 SNPs.

Main Results:

  • The prevalence of AtH genotypes (C/C, G/G) was similar in both CD and control groups.
  • Children with CD exhibited lower lactase activity than controls, irrespective of AtH SNP genotypes.
  • In controls, lactase activity was higher in those with C/T + G/A genotypes compared to C/C + G/G genotypes.

Conclusions:

  • No significant correlation was found between AtH SNPs (C/T-13910, G/A-22018) and coeliac disease (CD).
  • Children with C/C or G/G AtH genotypes do not seem to be at increased risk for CD.
Abstract

Related Concept Videos

Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
28.5K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.1K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
17.2K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
74
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
104
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
168